U.S. Biotech Stock News

Wave Life Sciences (WVE) shares have experienced a noticeable swing this month, sparking fresh interest among investors watching the biotech space. With a year-to-date decline of nearly 47%, some are reevaluating its current valuation. See our latest analysis for Wave Life Sciences. Wave Life Sciences’ share price has been on a rollercoaster this year, with a sharp slide of 47% year-to-date reflecting market caution despite some renewed buying in recent sessions. While the 1-year total...

EchoStar (SATS) shares have climbed roughly 2% in the past month, catching the attention of investors watching the company’s longer-term trajectory. Looking at the movement, it is interesting to see how EchoStar’s fundamentals could support continued momentum. See our latest analysis for EchoStar. EchoStar’s momentum is not limited to the past month. A 131.7% gain in share price over the last 90 days and a remarkable 201.7% year-to-date price return point to renewed optimism around growth and...

Earlier this week, Rothschild & Co Redburn downgraded Amazon to Neutral citing concerns about future cloud division growth and AI investment profitability, as technology sector valuations came under scrutiny causing a pullback across major companies. Despite recent strong AWS performance and high-profile cloud deals, the sector’s hesitation highlights the growing investor focus on when significant AI investments will begin to drive tangible financial results. We'll examine how analyst...

S&P Global (SPGI) just rolled out two new tools for private market managers, aiming to make complex compliance and portfolio monitoring smoother and faster. The recent launches focus heavily on real-time analytics and seamless data integration. See our latest analysis for S&P Global. Momentum around S&P Global has been lively this year, with a string of product launches, a recent office opening in Manchester, and a new share buyback plan signaling long-term confidence from management. Despite...

Diodes Incorporated recently announced the launch of the AL3069Q, an automotive-compliant 60V boost controller designed for backlight applications in infotainment panels, instrument clusters, and heads-up displays, offering high-precision current sink channels and advanced safety diagnostics. This product highlights Diodes' expanding presence in automotive electronics by supporting larger, high-efficiency LED displays and integrating comprehensive protection features for system...

Earlier this month, Cadre Holdings was highlighted as one of the best small-cap defense stocks following positive third-quarter earnings and renewed analyst attention. Management’s focus on global safety threats and ongoing national defense initiatives underscores expectations for resilient demand in the company’s core markets. We’ll explore how management’s emphasis on steady demand for protective equipment amid global instability could influence Cadre Holdings’ investment narrative. Find...

On November 18, 2025, PVH Corp. announced that Chief Financial Officer Zac Coughlin will depart at year-end to join Sirius XM, with longtime executive Melissa Stone named interim CFO and a global search for a permanent replacement underway. The company reaffirmed its third-quarter and full-year 2025 earnings guidance alongside this transition, highlighting a commitment to operational stability despite leadership changes at the financial helm. We'll explore how the CFO succession and the...

Insmed (INSM) has secured a major regulatory win, as the European Commission granted approval for BRINSUPRI as the first and only approved treatment for non-cystic fibrosis bronchiectasis in the European Union. This decision followed an accelerated assessment based on strong trial data and public health interest. See our latest analysis for Insmed. Insmed’s share price has gone from strength to strength, notching an impressive 23.9% return over the past month and surging more than 184%...

Earlier this year, Park Hotels & Resorts sold two of San Francisco’s largest hotels, Hilton and Parc 55, at a very large discount for US$408 million to Newbond Holdings and Conversant Capital after defaulting on a US$725 million renovation loan amid difficult tourism conditions. This transaction, involving nearly 10% of the city's hotel supply, reflects both the challenges and renewed investor willingness to back a recovery in downtown San Francisco hospitality. We'll examine how the...

Expand Energy (EXE) is gearing up for its spotlight at the Stephens Annual Investment Conference in Nashville, where Executive VP and COO Joshua J. Viets will address investors and analysts who are eager for management’s latest perspective. See our latest analysis for Expand Energy. Excitement around Expand Energy’s appearance at the conference comes amid a period of clear momentum for the stock, with a 10.2% 1-month share price return and longer-term tailwinds reflected in a 19.3% total...

CorMedix (CRMD) shares have seen activity recently, with investors keeping a close eye on its latest movements and company performance. Over the past month, the stock is down 14%; however, year-to-date it remains up by 18%. See our latest analysis for CorMedix. Despite a steep drop over the last month, CorMedix's 2024 share price return still suggests that investors are weighing long-term growth against recent volatility. While momentum has faded in recent weeks, the three-year total...

Jazz Pharmaceuticals (JAZZ) released results from its Phase 3 HERIZON-GEA-01 trial, showing Ziihera combinations led to marked improvements in survival measures compared to standard therapy in advanced HER2-positive gastroesophageal cancers. See our latest analysis for Jazz Pharmaceuticals. Jazz Pharmaceuticals’ shares have been on a tear lately, with a 25% jump over the past week alone as investors responded enthusiastically to the latest clinical trial update. Momentum has steadily built...

In the past week, Exponent’s President and CEO Catherine Corrigan exercised stock options, sold some shares under a trading plan, and still retains a substantial equity stake, while the company reported higher quarterly revenue and net profit compared to last year. An analyst at William Blair upgraded Exponent to 'Outperform' and expressed a positive outlook, highlighting increased confidence in the company amid recent insider sales activity. We'll explore how the combination of improved...

Cinemark Holdings (CNK) recently reported an annual net income growth of just over 20%, along with a 6% increase in yearly revenue. This performance gives investors fresh numbers to consider as they evaluate the company's ongoing recovery and future prospects. See our latest analysis for Cinemark Holdings. After a bumpy start to the year, Cinemark’s share price has rebounded with a 12% gain over the past month. However, its year-to-date share price return remains negative and its one-year...

IDACORP (IDA) has recently caught the attention of investors because of its steady track record and notable returns over the past month. With a year-to-date gain of 18%, IDACORP’s performance is prompting some fresh evaluation. See our latest analysis for IDACORP. Momentum for IDACORP has built impressively this year, with a 17.9% share price return year-to-date reflecting renewed investor optimism. While the past month saw a slight dip, the one-year total shareholder return of 10.7%...

Westlake Corporation recently completed a cash tender offer, reducing its outstanding debt by accepting US$253.73 million principal amount of its 3.600% Senior Notes due 2026, and declared a regular US$0.53 per share dividend for the third quarter of 2025, payable on December 11, 2025 to shareholders on record as of November 25, 2025. This combination of debt reduction and ongoing dividend distributions highlights Westlake's focus on maintaining balance sheet strength while delivering...

Tripadvisor (TRIP) drew investor attention after Bernstein gave positive feedback on the company's integration plan for Viator. The strategic approach, which highlights cost-saving potential, seems to have boosted confidence around Tripadvisor's turnaround possibilities. See our latest analysis for Tripadvisor. Tripadvisor’s 8.7% share price gain in the last day stands out against a year marked by wider declines, with a 30-day share price return of -11.6% and three-year total shareholder...

Trevi Therapeutics (TRVI) grabbed investor attention after reporting third quarter results showing its net loss narrowed compared to last year. The company also moved to file a universal shelf registration, providing added financial flexibility. See our latest analysis for Trevi Therapeutics. The buzz around Trevi Therapeutics isn’t just about earnings; the stock has seen its share price leap by 152% year-to-date, with the one-year total shareholder return soaring an even more impressive...

Primerica, Inc. has announced a share repurchase program authorized by its Board of Directors, allowing the company to buy back up to US$475 million of its shares through December 31, 2026. This buyback program gives Primerica added flexibility to return capital to shareholders and often reflects management's positive view on the company's future prospects. We'll explore how this substantial share buyback authorization could influence Primerica's investment narrative as outlined by...

In November 2025, Opendoor Technologies was added to both the S&P Global BMI Index and S&P TMI Index, while also announcing a special dividend of tradable warrants for shareholders and certain convertible noteholders. This period coincided with operational pressures stemming from a stagnant housing market, high levels of unsold inventory, and insider share sales, raising questions among investors about the platform's resilience and future profitability. We'll explore how persistent unsold...

Earlier this month, Qnity Electronics announced a delay in filing its 10-Q SEC report and affirmed a quarterly dividend of US$0.06 per share, payable on December 15, 2025, to shareholders of record as of November 28, 2025. The company's ongoing operational transition following its separation from DuPont is drawing focus, particularly as it manages both the costs and opportunities tied to independence and its semiconductor sector partnerships. We’ll explore how Qnity Electronics’ transition...

In recent weeks, Lennox International experienced sustained declines after posting mixed third-quarter results and lowering its full-year outlook, attributing challenges to softening HVAC demand, regulatory obstacles, and news of a legal investigation. Amid these pressures, the company’s Feel The Love initiative in October provided over 400 donated HVAC units to nonprofits and homeowners in need, underscoring ongoing community engagement despite market headwinds. We’ll explore how the...

Wondering if Ondas Holdings is truly a hidden gem or just caught up in hype? You're not alone. Evaluating its real value is the first step toward a smart investment decision. In the last twelve months, Ondas Holdings has increased by an incredible 659.3%, with a sharp 156.1% climb year-to-date, though recent weeks have brought some volatility. These dramatic price movements follow headlines about Ondas' expanding partnerships in the industrial wireless space and regulatory approvals for new...

On November 20, 2025, Texas Department of Transportation officials, Fluor Corporation, and local community members marked the groundbreaking of the State Highway 6 expansion in Bryan/College Station, Texas, a project to widen a critical 12-mile corridor serving key local and regional needs. This public milestone reflects Fluor’s execution progress on a vital infrastructure contract that supports the region’s mobility, supply chains, and emergency response capabilities. We’ll look at how...